Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01208415 · ClinicalTrials.gov registry record · NA
PRESERVE-Zenith® Iliac Branch System Clinical Study
A NA study of Aorto-iliac Aneurysms and Iliac Aneurysms, sponsored by Cook Group Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 19
- Study locations
NCT01208415: Completed NA study of Aorto-iliac Aneurysms and Iliac Aneurysms, sponsored by Cook Group Incorporated.
NCT01208415 is a NA study of Aorto-iliac Aneurysms and Iliac Aneurysms that has completed, run by Cook Group Incorporated. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 19 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01208415, a NA study of Aorto-iliac Aneurysms and Iliac Aneurysms, has completed, sponsored by Cook Group Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 19
- Study locations
Study Summary
The PRESERVE-Zenith® Iliac Branch System Clinical Study is a clinical trial to study the safety and effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation in combination with the Zenith® Connection Endovascular Stent/ConnectSX™ covered stent in the treatment of aorto-iliac and iliac aneurysms.
Primary Outcome
Patency-related intervention is defined as: Secondary intervention to treat a \> 60% stenosis of the internal iliac artery (as identified through CT, angiography, or duplex ultrasound and confirmed by core laboratory) associated with clinical symptoms. Of note, this not only includes patients with internal iliac artery stenosis following successful placement of the Zenith® Branch Endovascular Graft-Iliac Bifurcation and ConnectSX™, but also any cases of technical failure resulting in occlusion o
Conditions Studied
Interventions
- DEVICE Endovascular repair for aortoiliac or iliac aneurysms.
Study Locations (19)
Pennsylvania
- Hospital of the University of Pennsylvania - Philadelphia
- Allegheny General Hospital - Pittsburgh
- University of Pittsburgh Medical Center - Pittsburgh
California
- VA Palo Alto HCS - Palo Alto
- Stanford University Medical Center - Stanford
Florida
- Christine E. Lynn Heart and Vascular Institute - Boca Raton
- University of Florida - Gainesville
Missouri
- Washington University School of Medicine - St Louis
- Mercy Hospital East Communities - St Louis
New York
- Columbia University Medical Center - New York
- Weill Cornell Medical Center - New York
Georgia
- Emory University - Atlanta
Massachusetts
- University of Massachusetts - Worcester
Michigan
- William Beaumont Hospital - Royal Oak
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2011-01 |
| Est. Completion | 2017-10-10 |
| Phase | NA |
What the finished NCT01208415 record still lists
NCT01208415 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Aorto-iliac Aneurysms appearing as the primary indexed condition, and to 1 intervention - of which Endovascular repair for aortoiliac or iliac aneurysms. is the first listed.
NCT01208415 lists 19 locations in 13 states (Pennsylvania, California, Florida).
Frequently Asked Questions
What is clinical trial NCT01208415 about?
NCT01208415 is a clinical study titled "PRESERVE-Zenith® Iliac Branch System Clinical Study". The PRESERVE-Zenith® Iliac Branch System Clinical Study is a clinical trial to study the safety and effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation in combination with the Zenith® Connection Endovascular Stent/ConnectSX™ covered stent in the treatment of aorto-iliac and ilia...
What is the current status of trial NCT01208415?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2011-01. Estimated completion is 2017-10-10.
What conditions does trial NCT01208415 study?
This clinical trial studies the following conditions: Aorto-iliac Aneurysms, Iliac Aneurysms.
What interventions are being tested in trial NCT01208415?
The interventions under investigation include: Endovascular repair for aortoiliac or iliac aneurysms. (DEVICE).
Who is sponsoring clinical trial NCT01208415?
This trial is sponsored by Cook Group Incorporated, which has 31 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01208415 being conducted?
This trial has 19 study locations across California, Florida, Georgia, Massachusetts, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aorto-iliac Aneurysms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01208415's enrollment target sits among peer trials
40 1447th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia